医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Theradome Inc. Accelerates Global Expansion Through Distribution Partnership in the Chinese Market

2015年10月09日 PM06:50
このエントリーをはてなブックマークに追加


 

PLEASANTON, Calif.

Theradome, Inc. recently named Nanjing XJS Ltd. as its master distributor of the Theradome™ laser hair regrowth helmet in the Chinese market.

Nanjing XJS Ltd., a distributor of several international high-end home-use medical devices in China, sells in hundreds of pharmacies, shops, hospitals and retail outlets throughout China. Through the partnership, the Theradome™ products will be featured in all those channels and Chinese online shopping channels.

Theradome, which has been a successful new product in USA, is sold at more than 200 Bosley Medical terminals. “The 678nm laser light used by Theradome stimulates the mitochondria at the base of the hair follicle, where the stem cells that grow hair are located,” Dr. Tamim Hamid, CEO and inventor of Theradome, explained the uniqueness of Theradome.

In the Chinese hair care market which boasts a market value of RMB 33.6 billion ($5.5 billion), sales of Western hair-loss treatments grew 90 percent from 2007 to 2012. Because of its size and growth rate, Theradome, Inc. attached great importance to the distribution in the Chinese market and regards it as an important step in its global expansion.

“There is a big market space for non-drug hair-loss therapy in China. Chinese people are losing confidence in functional shampoo and traditional Chinese medicines for hair loss. We could not be more excited about this opportunity to distribute Theradome in China and to work with such an innovative company. We are confident that Theradome will achieve great success in the Chinese market in the near future,” said Leo Chan, CEO of Nanjing XJS Ltd. “The Chinese leading-chain hair restoration hospitals will exhibit and resell Theradome soon.”

Theradome Inc. has also announced that Nanjing XJS Ltd. would be the distributor of the coming hair care supplements branding Theradome.

For more Chinese information about Theradome, please visit:

http://www.theradome.com.cn/

View source version on businesswire.com: http://www.businesswire.com/news/home/20151009005246/en/

CONTACT

Theradome Inc.
Travis Culver, +1 323-937-1951
press@theradome.com

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • BioVectra与Keryx Biopharmaceuticals签署枸橼酸铁扩产协议
  • Eternity Healthcare Inc. Enters into Share Exchange Agreement with Guizho Tongren Healthy China Biotechnology Co. Ltd.
  • Takeda and TiGenix announce that Cx601 (darvadstrocel) has received a positive CHMP opinion to treat complex perianal fistulas in Crohn’s disease
  • Chi-Med Initiates Fruquintinib U.S. Clinical Trials
  • Orthocell Granted European Tendon Regeneration Patent